Carcinoma, Intraductal, Noninfiltrating
"Carcinoma, Intraductal, Noninfiltrating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
MeSH Number(s)
C04.557.470.200.025.275
C04.557.470.615.275
Concept/Terms
Carcinoma, Intraductal, Noninfiltrating- Carcinoma, Intraductal, Noninfiltrating
- Intraductal Carcinoma, Noninfiltrating
- Carcinoma, Noninfiltrating Intraductal
- Carcinomas, Noninfiltrating Intraductal
- Intraductal Carcinomas, Noninfiltrating
- Noninfiltrating Intraductal Carcinoma
- Noninfiltrating Intraductal Carcinomas
- Ductal Carcinoma In Situ
- Carcinoma, Intraductal
- Carcinomas, Intraductal
- Intraductal Carcinoma
- Intraductal Carcinomas
- DCIS
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Intraductal, Noninfiltrating".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Intraductal, Noninfiltrating".
This graph shows the total number of publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Harvard Catalyst Profiles by year, and whether "Carcinoma, Intraductal, Noninfiltrating" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 4 | 0 | 4 |
| 1996 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 2 | 5 |
| 2000 | 4 | 1 | 5 |
| 2001 | 13 | 1 | 14 |
| 2002 | 7 | 1 | 8 |
| 2003 | 11 | 3 | 14 |
| 2004 | 5 | 3 | 8 |
| 2005 | 5 | 6 | 11 |
| 2006 | 7 | 3 | 10 |
| 2007 | 5 | 3 | 8 |
| 2008 | 10 | 4 | 14 |
| 2009 | 12 | 4 | 16 |
| 2010 | 12 | 0 | 12 |
| 2011 | 17 | 5 | 22 |
| 2012 | 15 | 6 | 21 |
| 2013 | 16 | 3 | 19 |
| 2014 | 13 | 5 | 18 |
| 2015 | 27 | 8 | 35 |
| 2016 | 21 | 0 | 21 |
| 2017 | 23 | 3 | 26 |
| 2018 | 17 | 4 | 21 |
| 2019 | 21 | 1 | 22 |
| 2020 | 31 | 3 | 34 |
| 2021 | 22 | 2 | 24 |
| 2022 | 15 | 1 | 16 |
| 2023 | 17 | 0 | 17 |
| 2024 | 2 | 0 | 2 |
Below are the most recent publications written about "Carcinoma, Intraductal, Noninfiltrating" by people in Profiles.
-
ASO Visual Abstract: Racial and Ethnic Disparities in Outcomes after Breast-Conserving Therapy and Endocrine Therapy for DCIS-A Post Hoc Analysis of the NSABP B-35 Randomized, Clinical Trial. Ann Surg Oncol. 2024 02; 31(2):1010-1011.
-
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Ann Surg Oncol. 2024 May; 31(5):3120-3127.
-
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2316763120.
-
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):112-132.
-
Opportunities for De-Escalation of Axillary Surgery in Patients with Ductal Carcinoma in Situ with Microinvasion. Ann Surg Oncol. 2024 02; 31(2):726-728.
-
Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort. Jpn J Clin Oncol. 2023 Oct 04; 53(10):984-990.
-
Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial. Ann Surg Oncol. 2023 Dec; 30(13):8404-8411.
-
Diagnostic Pitfalls in Breast Cancer Pathology With an Emphasis on Core Needle Biopsy Specimens. Arch Pathol Lab Med. 2023 09 01; 147(9):1025-1038.
-
Impact of Surveillance Mammography Intervals Less Than One Year on Performance Measures in Women With a Personal History of Breast Cancer. Korean J Radiol. 2023 08; 24(8):729-738.
-
Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram. Breast Cancer Res Treat. 2023 Nov; 202(1):185-190.